Assessment of the hepatotoxic potential of organot in compounds containing 2,6-di-tert-butylphenol fragme


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article is devoted to the in vivo study of the effect of organotin compounds containing 2,6-di-tert-butylphenol fragment on liver mor- pho-functional state. The aim of this study was to evaluate the biochemical and histological changes in the liver with a single intragastric administration of bis (3,5-di-tert-butyl-4-hydroxyphenylthiolate) dimethyltin (Me3) and (3,5-di-tert-butyl-4-hydroxyphenylthiolate) triphenyltin (Me5) to Wistar rats (female) at the maximum tolerated dose (MTD) of 2000 mg/kg and 750 mg/kg, respectively. It was found that the introduction of Me3 and Me5 do not cause significant structural changes in liver, and the disorders are of a functional nature. The results of this work allow us to conclude that the hepatotoxicity of organotin compounds containing 2,6-di-tert-butylphenol is low, which opens up broad prospects for studying these compounds as candidates for antitumor drugs

全文:

受限制的访问

作者简介

M. Dodokhova

Rostov State Medical University

Email: dodohova@mail.ru
Ph.D. (Med.), Associate Professor, Department of Biomedicine and Neuroscience, and General and Clinical Biochemistry No. 2

A. Safronenko

Rostov State Medical University

Email: andrejsaf@mail.ru
Dr.Sc. (Med.), Professor, Department of Pharmacology and Clinical Pharmacology

I. Kotieva

Rostov State Medical University

Email: kukulik70@mail.ru
Dr.Sc. (Med.), Professor, Department of Pathological Physiology

E. Milaeva

Lomonosov Moscow State University

Email: milaeva@med.chem.msu.ru
Dr.Sc. (Chem.), Professor, Department of Medicinal Chemistry and Fine Organic Synthesis

D. Shpakovsky

Lomonosov Moscow State University

Email: dmshpak@mail.ru
Ph.D. (Chem.), Senior Researcher, Department of Medicinal Chemistry and Fine Organic Synthesis

Yu. Makarenko

Pathologic and Anatomical Bureau of the Russian Academy of Sciences

Email: markovich1962@yandex.ru
Ph.D. (Med.)

V. Trepel

Federal State Budgetary Institution "IMCEUAOSMP" of Roszdravnadzor

Email: vartantrepel.61@gmail.com
Ph.D. (Med.), Rostov-on-Don branch

M. Alkhuseyn-Kulyaginova

Rostov State Medical University

Email: rita.kuljaginva@rambler.ru
Senior Laboratory Assistant, Department of Chemistry

参考

  1. Состояние онкологической помощи населению России в 2019 году / Под ред. А.Д. Каприна, В.В. Старинского, А. О. Шахзадовой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2020; 239 с.
  2. Azad A., Chang P., Deepika D., et al. Real world experience of drug induced liver injury in patients undergoing chemotherapy. J. Clin. Gastroenterol. Hepatol. 2018; 2(3):18.
  3. Полунина Т.Е., Маев И.В. Лекарственный гепатит. Consilium medicum. Гастроэнтерология. 2008; 1:3-10.
  4. Ивашкин В.Т., Барановский А.Ю., Райхельсон К.Л. и др. Лекарственные поражения печени (клинические рекомендации для врачей). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2019; 29(1 ):101-131.
  5. Banti C.N., Hadjikakou S.K., Sismanoglu T., Hadjiliadis N. Anti-proliferative and antitumor activity of organotin (IV) compounds. An overview of the last decade and future perspectives. J. Inorg. Biochem. 2019; 194:114-152.
  6. Shpakovsky D.B., Banti C.N., Mukhatova E.M. et al. Synthesis, antiradical activity and in vitro cytotoxicity of novel organotin complexes based on 2,6-di-tert-butyl-4-mercaptophenol. Dalton Trans. 2014; 43:6880-6890.
  7. OECD Guideline for testing of chemicals. Acute Oral Toxicity -Fixed Dose Procedure No. 420. OECD Publishing, Paris, 2001.
  8. OECD, Test No. 425: Acute Oral Toxicity: Up-and-Down Procedure. OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, 2008. https://doi.org/10.1787/9789264071049-en
  9. Коптяева К.Е., Мужикян А.А., Гущин Я.А. и др. Методика вскрытия и извлечения органов лабораторных животных (крысы). Лабораторные животные для научных исследований. 2018; 2:71-92.
  10. Хабриев Р. У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М.: Медицина, 2005; 832 с.
  11. Aithal G.P., Watkins P.B., Andrade R.J., et al. Review. Case definition and phenotype standardization in drug-induced liver injury. Clin. Pharmacol. Ther. 2011; 89(6):806-815.
  12. Milaeva E.R., Tyurin V.Y., Gracheva Y.A. et al. Protective Effect of Meso-Tetrakis-(3,5-di-tert-butyl-4-hydroxyphenyl)porphyrin on the In Vivo Impact of Trimethyltin Chloride on the Antioxida-tive Defense System. Bioinorg. Chem. Appl. 2006; 2006:64927.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2021
##common.cookie##